BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32695773)

  • 1. Efficient Multiplex Genome Editing in
    Zhang J; Zhang D; Zhu J; Liu H; Liang S; Luo Y
    Front Bioeng Biotechnol; 2020; 8():726. PubMed ID: 32695773
    [No Abstract]   [Full Text] [Related]  

  • 2. CRISPR-Cpf1-Assisted Multiplex Genome Editing and Transcriptional Repression in Streptomyces.
    Li L; Wei K; Zheng G; Liu X; Chen S; Jiang W; Lu Y
    Appl Environ Microbiol; 2018 Sep; 84(18):. PubMed ID: 29980561
    [No Abstract]   [Full Text] [Related]  

  • 3. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing.
    Wang L; Wang H; Liu H; Zhao Q; Liu B; Wang L; Zhang J; Zhu J; Bao R; Luo Y
    Biotechnol Bioeng; 2019 Jun; 116(6):1463-1474. PubMed ID: 30730047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
    Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
    Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient cleavage resolves PAM preferences of CRISPR-Cas in human cells.
    Tang L; Yang F; He X; Xie H; Liu X; Fu J; Xi H; Lu X; Liu C; Song Z; Qu J; Zhao J; Gu F
    Cell Regen; 2019 Dec; 8(2):44-50. PubMed ID: 31709036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Efficiency Genome Editing of Streptomyces Species by an Engineered CRISPR/Cas System.
    Wang Y; Cobb RE; Zhao H
    Methods Enzymol; 2016; 575():271-84. PubMed ID: 27417933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient genome editing for Pseudomonas aeruginosa using CRISPR-Cas12a.
    Lin Z; Li H; He L; Jing Y; Pistolozzi M; Wang T; Ye Y
    Gene; 2021 Jul; 790():145693. PubMed ID: 33961975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cas9 protein variant VQR recognizes NGAC protospacer adjacent motif in rice].
    Xin GW; Hu XX; Wang KJ; Wang XC
    Yi Chuan; 2018 Dec; 40(12):1112-1119. PubMed ID: 30559100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas12a-Mediated Gene Deletion and Regulation in
    Zhao R; Liu Y; Zhang H; Chai C; Wang J; Jiang W; Gu Y
    ACS Synth Biol; 2019 Oct; 8(10):2270-2279. PubMed ID: 31526005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome Engineering in Rice Using Cas9 Variants that Recognize NG PAM Sequences.
    Hua K; Tao X; Han P; Wang R; Zhu JK
    Mol Plant; 2019 Jul; 12(7):1003-1014. PubMed ID: 30928636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cas9-NG Greatly Expands the Targeting Scope of the Genome-Editing Toolkit by Recognizing NG and Other Atypical PAMs in Rice.
    Ren B; Liu L; Li S; Kuang Y; Wang J; Zhang D; Zhou X; Lin H; Zhou H
    Mol Plant; 2019 Jul; 12(7):1015-1026. PubMed ID: 30928635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas nucleases and base editors for plant genome editing.
    Gürel F; Zhang Y; Sretenovic S; Qi Y
    aBIOTECH; 2020 Jan; 1(1):74-87. PubMed ID: 36305010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
    Hu X; Meng X; Liu Q; Li J; Wang K
    Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex gene editing and large DNA fragment deletion by the CRISPR/Cpf1-RecE/T system in Corynebacterium glutamicum.
    Zhao N; Li L; Luo G; Xie S; Lin Y; Han S; Huang Y; Zheng S
    J Ind Microbiol Biotechnol; 2020 Aug; 47(8):599-608. PubMed ID: 32876764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas genome editing to optimize pharmacologically active plant natural products.
    Dey A
    Pharmacol Res; 2021 Feb; 164():105359. PubMed ID: 33285226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR/Cas9-Based Editing of
    Tao W; Yang A; Deng Z; Sun Y
    Front Microbiol; 2018; 9():1660. PubMed ID: 30087666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPER/Cas in Plant Natural Product Research: Therapeutics as Anticancer and other Drug Candidates and Recent Patents.
    Dey A; Nandy S
    Recent Pat Anticancer Drug Discov; 2021; 16(4):460-468. PubMed ID: 34911411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving FnCas12a Genome Editing by Exonuclease Fusion.
    Wu Y; Yuan Q; Zhu Y; Gao X; Song J; Yin Z
    CRISPR J; 2020 Dec; 3(6):503-511. PubMed ID: 33346706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-efficiency multiplex genome editing of Streptomyces species using an engineered CRISPR/Cas system.
    Cobb RE; Wang Y; Zhao H
    ACS Synth Biol; 2015 Jun; 4(6):723-8. PubMed ID: 25458909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a CRISPR/Cas9-mediated gene-editing tool in Streptomyces rimosus.
    Jia H; Zhang L; Wang T; Han J; Tang H; Zhang L
    Microbiology (Reading); 2017 Aug; 163(8):1148-1155. PubMed ID: 28742008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.